Acadia Pharma ’s stock falls 15% after failed drug trial

One of Acadia Pharma’s drugs failed to meet goals of a late-stage trial about a schizophrenia treatment.#acadiapharmas
Source: Reuters: Health - Category: Consumer Health News Source Type: news